At Herondale, our most successful partnerships begin with a shared conviction: the people who built a business are essential to its next chapter. When we evaluate potential acquisitions, management quality and founder alignment rank alongside financial performance as core investment criteria. We look for businesses led by passionate operators who have built something durable — companies with loyal customer bases, strong employee cultures, and defensible market positions that were earned over years, not engineered overnight.

Our approach to partnering with founder-led businesses is rooted in operational collaboration rather than top-down restructuring. We seek companies where the existing management team wants to continue leading day-to-day operations, with Herondale providing strategic resources, capital, and institutional support to accelerate growth initiatives that founders may not have had the bandwidth or balance sheet to pursue independently. This includes expanding into adjacent markets, professionalizing back-office operations, executing add-on acquisitions, and investing in technology and talent that drive long-term value creation.

For business owners considering a transition, the right partner matters as much as the right valuation. We structure transactions that respect the legacy founders have built while creating meaningful upside through a shared growth plan. Whether it is a full acquisition, a majority recapitalization, or a partnership that allows an owner to de-risk while staying involved, our goal is always the same: to work alongside great people to build something greater. If you are a business owner exploring your options, we welcome the conversation.

Private credit has emerged as one of the defining forces in middle-market dealmaking, and 2026 is shaping up to be a pivotal year for the asset class. The U.S. private credit market has grown from $500 billion to approximately $1.3 trillion over the past five years, and Moody’s projects it will exceed $3 trillion in assets under management by 2028. For private equity firms and independent sponsors, private credit has become a permanent fixture of deal financing — offering speed, flexibility, and certainty of execution that traditional bank lending often cannot match.

The supply-demand dynamics heading into 2026 favor lenders. Nearly $1 trillion in U.S. corporate debt is set to mature between 2026 and 2028, much of it direct-lending-style loans with bullet maturities that were underwritten during the low-rate environment of 2020-2022. This refinancing wave, combined with rising M&A deal volume, is expected to gradually overtake private credit supply — allowing lenders to preserve discipline, strengthen terms, and capture meaningful illiquidity premiums over public markets. Morgan Stanley estimates asset yields on directly originated first lien loans will trough around 8.0-8.5% in 2026, still elevated by historical standards and in the upper half of their 12-year range.

For borrowers and deal sponsors, the private credit landscape demands a more strategic approach than in years past. Banks returned aggressively to leveraged lending in 2025, refinancing nearly $34 billion in private credit facilities, which means sponsors now have more options but also face more complexity in structuring optimal capital solutions. The most successful transactions in 2026 will be those where sponsors pair operational expertise with creative financing — leveraging private credit’s flexibility for acquisition structures like delayed-draw facilities, unitranche loans, and preferred equity that traditional lenders are less equipped to offer.

Artificial intelligence is no longer a future consideration for private equity — it is actively reshaping how firms source deals, conduct due diligence, and create value within portfolio companies. Since 2020, private equity has invested over $1 trillion in technology, including $200 billion in data centers, semiconductors, and energy infrastructure. But the more immediate impact for middle-market firms lies in how AI tools are being deployed operationally: automating financial analysis during diligence, identifying acquisition targets through pattern recognition, and benchmarking portfolio company performance against industry datasets in real time.

On the deal sourcing and evaluation side, AI-driven platforms can now scan thousands of potential targets, flagging businesses that match specific investment criteria based on financial metrics, growth trajectories, and market positioning. During due diligence, natural language processing tools accelerate contract review and risk identification, compressing timelines that traditionally stretched weeks into days. Post-acquisition, AI is enabling portfolio companies to optimize pricing, reduce customer churn, and streamline supply chains — translating directly into EBITDA improvement and value creation at exit.

The firms gaining a competitive edge in 2026 are those embedding AI into their core workflows rather than treating it as a standalone initiative. BDO, Cherry Bekaert, and Morgan Stanley all identify AI adoption as a primary differentiator in the current PE landscape. For middle-market operators in particular, where operational improvement drives returns more than financial engineering, AI-enabled efficiency gains can be the difference between median and top-quartile performance. The question is no longer whether PE firms should adopt AI, but how quickly they can integrate it into their investment process and portfolio operations.

The U.S. hotel industry entered 2026 on stronger footing than most expected. According to STR data, the first two months of the year outperformed forecasts, and the American Hotel & Lodging Association projects the hotel workforce will grow by more than 30,000 jobs this year, bringing direct employment to approximately 2.2 million. Major demand catalysts — including the FIFA World Cup and America250 celebrations — are expected to lift travel volumes and drive rate growth in key markets throughout the year.

However, the headline optimism masks a structural pressure point that sophisticated investors are watching closely: the hotel debt maturity wall. Approximately $875 billion in commercial and multifamily mortgage debt is expected to mature in 2026, and hotel assets face particularly challenging refinancing conditions. Hotel mortgage spreads have widened to 375 basis points over treasuries — a 125-150 basis point premium versus multifamily and industrial — reflecting lender caution around hospitality-specific liquidity risk. For loans originated during the low-rate era of 2018-2022, this spread expansion transforms routine refinancings into consequential capital structure events.

This dynamic creates a bifurcated market. Investment-grade platforms with balance sheet strength can refinance comfortably, while smaller operators and non-rated portfolios face SOFR + 500 basis points or higher, the widest spread since 2009. For patient capital with operational expertise and flexible structuring capabilities, this dislocation opens a compelling acquisition window — the ability to acquire quality hotel assets at or below replacement cost in select markets where refinancing pressure forces motivated sellers to transact. The consensus among hospitality experts is clear: the era of “kicking the can” on hotel transactions is over.

After years of subdued deal activity, middle-market M&A is showing clear signs of acceleration in 2026. Financing conditions have stabilized, valuation gaps between buyers and sellers are narrowing, and private equity firms hold near-record levels of dry powder ready for deployment. Industry surveys from Cherry Bekaert, BDO, and Nixon Peabody all point to the same conclusion: pent-up demand is converting into real deal flow, particularly in the lower-middle and middle-market segments where Herondale operates.

Several sectors are commanding premium valuations and attracting intense buyer interest. Technology — particularly AI infrastructure, cybersecurity, and software — remains a centerpiece of deal activity as companies across industries pursue acquisitions to accelerate digital transformation. Healthcare services continue to generate strong activity, driven by demographic trends, cost pressures, and the shift toward integrated care models. B2B services also draw significant attention from both strategic buyers and private equity firms, thanks to recurring revenue models and scalable platforms that lend themselves to buy-and-build strategies.

Creative deal structures like earnouts, seller notes, and rollover equity remain prevalent as tools to bridge remaining valuation gaps, though these require careful structuring to avoid disputes. Demographic shifts are also playing a role — aging business owners who have weathered volatility since 2020 are increasingly motivated to transact rather than wait for perfect conditions. For well-capitalized, operationally focused firms, 2026 represents a meaningful window to acquire quality businesses at reasonable entry points before the broader market fully reprices.

Introduction

Healthcare is undergoing a rapid transformation, driven by advancements in technology, shifting patient expectations, and evolving policies. The traditional model of care, characterized by in-person doctor visits and hospital-based treatment, is being reshaped by digital health solutions, telemedicine, and personalized care approaches. In this article, we explore the key trends shaping the future of healthcare and how these changes are improving patient outcomes while making healthcare more accessible and efficient.

The Rise of Telemedicine

One of the most significant shifts in healthcare services is the widespread adoption of telemedicine. The COVID-19 pandemic accelerated the need for remote consultations, making telehealth a mainstream option for patients and providers alike. Patients can consult doctors from the comfort of their homes, reducing travel time and costs. Rural and underserved populations now have greater access to medical specialists. Virtual consultations help reduce hospital overcrowding and streamline healthcare delivery. As telemedicine platforms continue to evolve, integrating artificial intelligence and machine learning will further enhance diagnostic accuracy and patient engagement.

Artificial Intelligence and Machine Learning in Healthcare

AI and machine learning are revolutionizing the way healthcare providers diagnose, treat, and manage diseases. AI-powered tools analyze X-rays, MRIs, and CT scans with remarkable accuracy, assisting radiologists in early disease detection. Predictive analytics can forecast disease outbreaks, patient deterioration, and treatment outcomes, enabling proactive intervention. AI-driven insights help doctors tailor treatments based on individual patient data, optimizing care effectiveness. The integration of AI in healthcare is not only enhancing patient outcomes but also improving efficiency in hospitals and clinics by reducing administrative burdens and automating routine tasks.

Wearable Technology and Remote Patient Monitoring

Wearable devices, such as smartwatches and fitness trackers, are playing a crucial role in preventive healthcare. Continuous monitoring can alert users to irregular heart rates, blood pressure fluctuations, and other potential health risks. Patients with conditions like diabetes and hypertension can track their health metrics and share data with their healthcare providers. With advancements in biosensors and AI-driven analytics, wearable technology is expected to become even more sophisticated in predicting and preventing medical conditions.

The Shift Toward Value-Based Care

Traditional healthcare models often prioritize the quantity of services provided, but there is a growing shift toward value-based care. This model emphasizes patient outcomes and overall healthcare quality rather than the volume of treatments or procedures. It encourages early screenings, vaccinations, and lifestyle changes to prevent chronic illnesses. Healthcare providers are rewarded based on patient health improvements rather than the number of visits or tests conducted. Value-based care is transforming the healthcare industry by focusing on long-term health and cost-effectiveness, benefiting both patients and providers.

Looking Ahead

The healthcare industry is experiencing a dynamic shift, with technology and innovation driving fundamental changes in service delivery. Telemedicine, AI, wearable technology, and value-based care are revolutionizing patient care, making it more accessible, efficient, and personalized. As these trends continue to evolve, the future of healthcare promises improved patient outcomes and a more streamlined system that benefits providers and patients alike. For investors, the convergence of these trends creates compelling opportunities across healthcare services, technology, and life sciences.